Genetics is the dominant risk factor for familial breast, prostate, and colorectal cancers
Major study links two new genetic variants to breast cancer
A study of people who were adopted identified genetics as the dominant risk factor in familial breast, prostate, and colorectal cancers. These new findings are based on studies of population registries by researchers at the Centre for Primary Health Care Research at Lund University and Region Skåne in Sweden.
"The results of our study do not mean that [a person's] lifestyle is not important for the individual's risk of developing cancer, but it suggests that the risk for the three most common types of cancer is dependent to a greater extent on genetics", said Bengt Zöller, MD, PhD, a reader at Lund University who led the study. The study was published in the European Journal of Cancer (2014; doi:10.1016/j.ejca.2014.05.018).
The researchers studied adoptees born in Sweden in relation to both their biological parents and their adoptive parents. The Swedish multigeneration register and the cancer register were used to monitor 70,965 adopted men and women. They were all born between 1932 and 1969 and developed breast cancer, prostate cancer, or colorectal cancer between the years 1958 and 2010. Using registry studies, the researchers also looked at their adoptive and biological parents over the same period.
The risk of cancer in adoptees with at least one biological parent who had had the same cancer was 80% higher for breast cancer, prostate cancer, and colorectal cancer than for a control group without a biological parent with the same cancer. There was, however, no higher risk for persons with adoptive parents affected by breast cancer, prostate cancer, or colorectal cancer than for a control group. Adoptees with a biological parent with cancer also developed the disease at a younger age than those without a biological parent with the same cancer. The age at which an person developed cancer was not, however, affected by whether an adoptive parent had had the same cancer.
The results are an important indicator of the significance of hereditary factors for breast, prostate, and colorectal cancer, according to Zöller.
"The occurrence of breast cancer, prostate cancer, and colorectal cancer in biological parents is an important risk factor that should be included in patients' medical history and examinations. It is therefore important that doctors ask about family history so that they can decide whether further tests are needed," said Zöller.